跳至主要内容
临床试验/ACTRN12623001047684
ACTRN12623001047684招募中Unknown

SNIF study: Efficacy of nasally inhaled isopropyl alcohol for nausea in the intensive care unit: A randomised clinical trial

Royal Adelaide Hospital0 个研究点目标入组 60 人开始时间: 2023年9月27日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients admitted to the Intensive Care Unit at the Royal Adelaide Hospital will be recruited if they meet all of the following inclusion Criteria:
  • 1. Reports symptom of nausea or witnessed episode of vomiting / dry retching
  • 2. Would be initiated on PONV protocol management
  • 3. Aged 18 or above
  • 4. Self-ventilating

排除标准

  • Exclusion Criteria:
  • 1. Allergy to isopropyl alcohol
  • 2. Allergy to ondansetron
  • 3. Inability to breathe through the nose
  • 4. Inability to give informed consent
  • 5. Mental or physical state precluding accurate assessment of nausea/ satisfaction scores
  • 6. Administration of antiemetic medication within the preceding 8 hours
  • 7. Administration of medication known to produce nausea when exposed to alcohol within the preceding 24 hours (e.g. Metronidazole, Disulfiram, Tinidazole, Trimethoprim-Sulfamethoxazole)
  • 8. Symptoms of nausea or vomiting for > 24 hours
  • 9. Pregnancy

研究者

相似试验

SNIF study: Efficacy of nasally inhaled isopropyl... | 临床试验